Treatment of Ovarian Carcinoma: Possibilities for Progress (Q39918078)

15 September 2017

1 reference

title

Treatment of Ovarian Carcinoma: Possibilities for Progress (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

4 February 2023

1 reference

Bagley CM Jr

1

1 reference

15 September 2017

Young RC

2

1 reference

15 September 2017

Canellos GP

3

1 reference

15 September 2017

DeVita VT

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 October 1972

1 reference

15 September 2017

26 October 1972

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4561148

full work available at URL

4 February 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197210262871705

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

The New England Journal of Medicine

4 February 2023

published in

1 reference

15 September 2017

287

1 reference

15 September 2017

856-862

1 reference

15 September 2017

17

1 reference

The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961

15 September 2017

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Chemotherapy in the treatment of cancer of the ovary.

4 February 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

The management of ovarian carcinoma--a review of 420 cases

4 February 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Primary cancer of the ovary An analysis of 349 cases

4 February 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Endometrioid carcinoma of the ovary.A clinicopathologic study of 75 cases

4 February 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Ovarian cancer with special regard to radiotherapy

4 February 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Megavoltage radiation therapy and lymphangiography in ovarian cancer

4 February 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy, and radiotherapy

4 February 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Is conservative therapy ever justified in stage I (IA) cancer of the ovary?

4 February 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

A critical assessment of the value of x-ray therapy in primary ovarian carcinoma

4 February 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Postoperative irradiation for ovarian carcinoma with the cobalt-60 moving strip technique

4 February 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Total abdominal irradiation using cobalt 60 moving strip technique

4 February 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

The value of postoperative intraperitoneal injection of radiocolloids in early cancer of the ovary

4 February 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

The efficacy of chemotherapeutic agents in the management of disseminated gynecologic cancer

4 February 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

The role of chemotherapy in the treatment of gynecologic malignancy

4 February 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Disseminated carcinoma of the ovary treated by L-phenylalanine mustard

4 February 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma

4 February 2023

39

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Five years clinical experience with 5-fluorouracil

4 February 2023

41

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Observations on gynecologic malignancy treated with 5-fluorouracil

4 February 2023

42

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Treatment of cancer with weekly intravenous 5-fluorouracil.Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG)

4 February 2023

43

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Prolonged low-dosage administration of hexamethylmelamine (NC 13875)

4 February 2023

45

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Progesterone in the Treatment of Advanced Malignant Tumours of Breast, Ovary and Uterus

4 February 2023

48

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Management of ovarian carcinoma, Surgery, irradiation, and chemotherapy

4 February 2023

52

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

Adjuvant therapy for advanced ovarian malignancy

4 February 2023

53

1 reference

https://api.crossref.org/works/10.1056/NEJM197210262871705

4 February 2023

Identifiers

1 reference

release_zyqnudv625c3hh3lmmnx6bnky4

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zyqnudv625c3hh3lmmnx6bnky4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference